- Cancers arising from the tissues of the colon or rectum are classified as colon cancer and rectal cancer, and together they are referred to as colorectal cancer.
- The primary related factor is acquired DNA changes, and in some cases, genetic predisposition along with lifestyle and environmental factors influence the risk.
- The core process involves changes in genetic material disrupting the regulation of cell proliferation and damage control, leading to the accumulation of abnormal cells and tumor formation.
- Representative manifestations include changes in bowel habits, bloody stools, abdominal gas, bloating, cramping, unexplained weight loss, and fatigue; there may be no symptoms in the early stages.
- Risk factors include advanced age, personal or family history of colorectal cancer, history of adenoma, Lynch syndrome, FAP, long-standing ulcerative colitis or Crohn's disease, smoking, obesity, and excessive alcohol consumption.
- The natural course begins in the asymptomatic stage and may present with changes in bowel habits or bleeding; the progression varies depending on the degree of advancement and tumor location.
- If symptoms or screening abnormalities are present, diagnosis is made by combining physical examination, digital rectal examination, colonoscopy or related tests, biopsy, and a combination of blood and tissue tests.
- Since screening tests are for early detection in asymptomatic individuals and confirmatory tests are separate, the stage, prognosis, and treatment should not be determined based on test results alone.
- Management is carried out by combining surgery, drug therapy, radiation therapy, and follow-up, while also considering the location and extent of the cancer, as well as the patient's age, general condition, and health issues.
- The treatment categories presented in MedlinePlus include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy, and in some situations, local therapy or active surveillance for rectal cancer is considered.